Advertisement
Canada markets close in 1 hour 31 minutes
  • S&P/TSX

    22,043.98
    +172.02 (+0.79%)
     
  • S&P 500

    5,075.36
    +64.76 (+1.29%)
     
  • DOW

    38,519.49
    +279.51 (+0.73%)
     
  • CAD/USD

    0.7321
    +0.0020 (+0.27%)
     
  • CRUDE OIL

    83.34
    +1.44 (+1.76%)
     
  • Bitcoin CAD

    91,239.79
    +334.33 (+0.37%)
     
  • CMC Crypto 200

    1,436.46
    +21.70 (+1.53%)
     
  • GOLD FUTURES

    2,342.00
    -4.40 (-0.19%)
     
  • RUSSELL 2000

    2,007.81
    +40.33 (+2.05%)
     
  • 10-Yr Bond

    4.5900
    -0.0330 (-0.71%)
     
  • NASDAQ

    15,727.60
    +276.29 (+1.79%)
     
  • VOLATILITY

    15.95
    -0.99 (-5.84%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6835
    -0.0015 (-0.22%)
     

New Strong Buy Stocks for January 2nd

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:

Builders FirstSource, Inc. (BLDR): This company that manufactures and supplies building materials has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.9% over the last 60 days.

Builders FirstSource, Inc. Price and Consensus

 

Builders FirstSource, Inc. Price and Consensus
Builders FirstSource, Inc. Price and Consensus

Builders FirstSource, Inc. price-consensus-chart | Builders FirstSource, Inc. Quote

HomeStreet, Inc. (HMST): This company that provides commercial and consumer banking services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.7% over the last 60 days.

ADVERTISEMENT

HomeStreet, Inc. Price and Consensus

 

HomeStreet, Inc. Price and Consensus
HomeStreet, Inc. Price and Consensus

HomeStreet, Inc. price-consensus-chart | HomeStreet, Inc. Quote

Alexion Pharmaceuticals, Inc. (ALXN): This company that develops and commercializes various therapeutic products has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 90 days.

Alexion Pharmaceuticals, Inc. Price and Consensus

 

Alexion Pharmaceuticals, Inc. Price and Consensus
Alexion Pharmaceuticals, Inc. Price and Consensus

Alexion Pharmaceuticals, Inc. price-consensus-chart | Alexion Pharmaceuticals, Inc. Quote

ManTech International Corporation (MANT): This company that provides technology solutions and services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.

ManTech International Corporation Price and Consensus

 

ManTech International Corporation Price and Consensus
ManTech International Corporation Price and Consensus

ManTech International Corporation price-consensus-chart | ManTech International Corporation Quote

PCTEL, Inc. (PCTI): This company that delivers performance critical telecom solutions has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.

PCTEL, Inc. Price and Consensus

 

PCTEL, Inc. Price and Consensus
PCTEL, Inc. Price and Consensus

PCTEL, Inc. price-consensus-chart | PCTEL, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention.

See 7 handpicked stocks now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
PCTEL, Inc. (PCTI) : Free Stock Analysis Report
 
ManTech International Corporation (MANT) : Free Stock Analysis Report
 
HomeStreet, Inc. (HMST) : Free Stock Analysis Report
 
Builders FirstSource, Inc. (BLDR) : Free Stock Analysis Report
 
Alexion Pharmaceuticals, Inc. (ALXN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research